Clinical Trials Logo

Clinical Trial Summary

Obtain preliminary safety and performance data on a settings initialization and adaptation algorithm used in conjunction with closed-loop control.

Clinical Trial Description

This feasibility study is a prospective, single arm, single center study with a run-in phase, followed by 13 weeks of Control-IQ technology use. By using an algorithm to more accurately initialize insulin delivery settings and adapt them over time, faster than typical HCP visits, users onboarding from multiple daily injections (MDI) will reach optimal glycemic outcomes faster. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT05204134
Study type Interventional
Source Tandem Diabetes Care, Inc.
Status Active, not recruiting
Phase N/A
Start date March 24, 2022
Completion date October 30, 2022

See also
  Status Clinical Trial Phase
Completed NCT05109520 - Evaluation of Glycemic Control and Quality of Life in Adults With Type 1 Diabetes During Continuous Glucose Monitoring When Switching to Insulin Glargine 300 U/mL
Recruiting NCT04016987 - Automated Structured Education Based on an App and AI in Chinese Patients With Type 1 Diabetes N/A
Recruiting NCT04190368 - Team Clinic: Virtual Expansion of an Innovative Multi-Disciplinary Care Model for Adolescents and Young Adults With Type 1 Diabetes N/A
Active, not recruiting NCT04668612 - Dual-wave Boluses in Children With Type 1 Diabetes Insulin Boluses in Children With Type 1 Diabetes N/A
Active, not recruiting NCT02837094 - Enhanced Epidermal Antigen Specific Immunotherapy Trial -1 Phase 1
Recruiting NCT05418699 - Real-life Data From Diabetic Patients on Closed-loop Pumps
Completed NCT04084171 - Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6 N/A
Recruiting NCT05379686 - Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes N/A
Withdrawn NCT04259775 - Guided User-initiated Insulin Dose Enhancements (GUIDE) to Improve Outcomes for Youth With Type 1 Diabetes N/A
Not yet recruiting NCT05139784 - BeAT1D: Benign Autoimmunity and Type 1 Diabetes
Not yet recruiting NCT05300022 - Technology Knowledge Optimization in Type 1 Diabetes (TeKnO T1D): Parents N/A
Not yet recruiting NCT05487534 - Do "Sugar Swings" Impact the Brain Function and the Eating Behaviors of People With Type 1 Diabetes
Recruiting NCT01600924 - Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes
Completed NCT02897557 - Insulet Artificial Pancreas Early Feasibility Study N/A
Completed NCT02855307 - Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes Phase 2
Completed NCT02750527 - Pediatric Population Screening for Type 1 Diabetes and Familial Hypercholesterolemia in Lower Saxony, Germany
Completed NCT02914886 - Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS) Phase 4
Active, not recruiting NCT02442544 - Prebiotic Fiber Supplement in T1DM Children Early Phase 1
Completed NCT02556398 - Use of Mobile-based Technologies to Improve Diabetes Self-management and Postprandial Glucose Control N/A
Completed NCT02544321 - Bromocriptine Quick Release (BCQR) as Adjunct Therapy in Type 1 Diabetes Phase 2